You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TEVA Sale Disclosure
Weiss Amir · SEC Form 4 · Filed Aug 25, 2026
Sale
Calculated transaction value
$261.22K
Weiss Amir Chief Accounting Officer
TEVA
Transaction date
Aug 21, 2026
Public filing date
Aug 25, 2026
Filing lag
Filed 4 days later
TEVA daily price context
Close on/before transaction
$37.34
Aug 21, 2026
First close after public filing
$37.92
Aug 26, 2026
30-day return after filing
+6.07%
Through Sep 24, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 6,945 shares @ $37.61
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-365116
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$452.23K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Teva Pharmaceutical Industries Ltd TEVA | Sale | Aug 21, 2026 | $94.08K |
| Teva Pharmaceutical Industries Ltd TEVA | Exercise | Aug 21, 2026 | $47.9K |
| Teva Pharmaceutical Industries Ltd TEVA Current | Sale | Aug 21, 2026 | $261.22K |
| Teva Pharmaceutical Industries Ltd TEVA | Exercise | Aug 21, 2026 | $49.02K |